The legislative effort is an attempt to fight the nearly 300 percent increase in the cost of the life saving drug, according to the report.
“I believe there should be transparency across the health care system,” Sen. Yvanna Cancela, D-Nev., who sponsored the bill, told Kaiser Health News.
Nevada would be the first state to track insulin manufacturer profits, as bills addressing the escalating drug costs in other states have stalled.
More articles on supply chain:
AstraZeneca divests migraine drug for $302M
Advocacy group calls for FDA action on Bayer’s birth control device
Walmart pledges to slash supply chain greenhouse gas emission by 1B tons
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
